In the US, Votrient (pazopanib systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Renal Cell Carcinoma.
US matches:
- Votrient
Ingredient matches for Votrient
Pazopanib
Pazopanib hydrochloride (a derivative of Pazopanib) is reported as an ingredient of Votrient in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment